111 results
Page 4 of 6
6-K
EX-99.2
99eww4qy71i
28 Aug 20
Mesoblast Well Prepared Ahead of First Potential US Product Launch
8:48pm
6-K
30c06p254rb 3wb69
29 May 20
Current report (foreign)
12:00am
6-K
EX-99.1
3dyvt2wm3h3bm3v
29 May 20
Current report (foreign)
12:00am
6-K
EX-99.2
rgj4p1flcx4o2fy0k
29 May 20
Current report (foreign)
12:00am
6-K
gh1or0sk
28 Feb 20
Provided to the Asx Under Listing Rule 4.2A
12:00am
6-K
EX-99.1
uxpgevp8 lhsubkwhko
4 Feb 20
Mesoblast Quarterly Cash Flow Report
12:00am
6-K
EX-99.2
8os3ggegdzkmgd
22 Jan 20
Mesoblast Presents Commercial Plans at 2020 Biotech Showcase In San Francisco
4:49pm
6-K
EX-99.2
qaet6gbdr t6cdcn
29 Nov 19
Current report (foreign)
6:47am
6-K
tj5xhk 2wbe1
27 Nov 19
Current report (foreign)
6:04am
6-K
EX-99.1
ebj3w os3eyt4wsbce
27 Nov 19
Continued Increase in Revenues and Strong Balance Sheet
6:04am
6-K
EX-99.2
zdjmbi40vw b1ekt
27 Nov 19
Continued Increase in Revenues and Strong Balance Sheet
6:04am
6-K
EX-99.1
v0vixdudizc2f
7 Nov 19
Mesoblast Quarterly Cash Flow Report
12:00am
6-K
EX-99.2
mcx4a3swq fdamkv7vvd
1 Nov 19
Appointment of Joint Company Secretary
6:02am
6-K
EX-99.1
9l1vm9xjed5jpl
21 Oct 19
Mesoblast and Lonza Enter into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
8:19pm
6-K
EX-99.2
5uwv 7vycy7vz
11 Sep 19
Current report (foreign)
6:35am
6-K
EX-99.1
8zsiy1su
6 Sep 19
Mesoblast Reports 2019 Full Year Results
6:35am